CVE-2022-26239 — MEDIUM (5.5)

Q: How severe is CVE-2022-26239?

CVE-2022-26239 has been rated MEDIUM with a CVSS base score of 5.5/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2022-26239?

Check the references section above for vendor advisories and patch information. Affected products include: Beckmancoulter Remisol Advance, Microsoft Windows.

Vulnerability Description

The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

CVSS Score

5.5

MEDIUM

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

LOCAL

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

NONE

Availability

NONE

Affected Products

Vendor	Product	Versions
Beckmancoulter	Remisol Advance	<= 2.0.12.1
Microsoft	Windows	-

Related Weaknesses (CWE)

CWE-732

References

https://pastebin.com/1QEHrj01Third Party Advisory
https://www.beckmancoulter.com/products/clinical-information-management-tools/reProduct
https://pastebin.com/1QEHrj01Third Party Advisory
https://www.beckmancoulter.com/products/clinical-information-management-tools/reProduct

FAQ

What is CVE-2022-26239?

CVE-2022-26239 is a vulnerability with a CVSS score of 5.5 (MEDIUM). The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libr...

How severe is CVE-2022-26239?

CVE-2022-26239 has been rated MEDIUM with a CVSS base score of 5.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-26239?

Check the references section above for vendor advisories and patch information. Affected products include: Beckmancoulter Remisol Advance, Microsoft Windows.